MSS/ MMRp
Who we are
Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
Mebendazole as Adjuvant Treatment for Colon Cancer
Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Pembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery
